Results per Page:
Two steps forward, one step back for targeting NKG2D in cancer treatment
From the Strong Lab in the Basic Sciences Division
When it comes to cancer trials, what’s the (end)point?
New endpoint in multiple myeloma could mean faster drug approvals. Are more endpoint tweaks on the way?
Una dosis de bortezomib por semana es suficiente para tratar el mieloma múltiple
Del Dr. Rahul Banerjee, División de Investigación Clínica
Caregivers know compassion is critical; staying organized is, too
One woman shares tips on caring for a spouse going through blood cancer treatment
Obliteride unites community for cancer cures
Registration opens for Fred Hutch’s summer bike ride, 5K fundraiser
Dead to me? Insights into a tumor’s necrotic core
Research from Cheung Lab reveals role for ‘dead zone’ within cancers as a launch system for metastatic spread
One-in-four cancer patients lack immunity to measles
From the Vaccine and Infectious Disease Division and the Fred Hutch/University of Washington Cancer Consortium
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news